Despite the importance of achieving cardiometabolic goals beyond blood pressure, in the health of hypertensives, no comprehensive assessment of these characteristics has been performed in whole countries. We studied in 2008-2010 a total of 11 957 individuals representative of the Spanish population aged ≥18 years. Information on cardiometabolic characteristics was collected at the participants' homes, through structured questionnaires, physical examination, and fasting blood samples. A total of 3983 individuals (33.3%) had hypertension (≥140/90 mm Hg or current antihypertensive drug treatment), 59.4% were aware of their condition, 78.8% treated among those aware, and 48.5% controlled among those aware and treated (22.7% of all hypertensives). Of the aware hypertensives, 13.8% had a body mass index <25 kg/m 2 , 38.6% consumed <2.4 g/d of sodium, 19.3% were diabetic with 61% attaining goal hemoglobin A1c <6.5%, whereas 42.3% had hypercholesterolemia, with 38.1% reaching goal low-density lipoprotein <115 mg/dL. Only 30.7% of overweight patients received a prescription of specific method for weight loss, 17.4% of daily smokers were offered a smoking cessation strategy, and 15.8% of older patients were given a flu shot. Aware and unaware hypertensives showed a similar frequency of some lifestyle, such as adequate physical activity. In conclusion, in a European country with a well-developed, free-access healthcare system, achievement of many cardiometabolic goals among hypertensives is poor. Moreover, a serious deficiency in hypertension awareness and in the effectiveness of some lifestyle interventions among aware hypertensives is present. Greater effort is needed in the management of coexisting risk factors and on lifestyle medical advice to improve the cardiometabolic health of hypertensives. (Hypertension. 2012;60:898-905.) See Editorial Commentary, pp 891-893 by guest on April 5, 2017 http://hyper.ahajournals.org/ Downloaded from BMI indicates body mass index; LDL-c, low-density lipoprotein cholesterol; CVD, cardiovascular disease; BP, blood pressure; high CVD risk, previous CVD, diabetes mellitus, or SCORE risk (10-year risk of CVD death for each patient using the SCORE [Systematic COronary Risk Evaluation] equation for low-risk European regions) ≥5%. Potential recommendation for statins is a high CVD risk. Potential recommendations for low-dose aspirin (<500 mg/d) are previous CVD or >50 y with slight increase in creatinine (1.3-1.5 mg/dL in men and 1.2-1.4 mg/dl in women) or elevated CVD risk (SCORE ≥10%) among controlled hypertensives. by guest on April 5, 2017 http://hyper.ahajournals.org/ Downloaded from Perspectives In Spain, 3 of 4 hypertensive patients are inadequately managed, because they either are unaware of their condition (40% of all hypertensives!), are untreated, or are uncontrolled. by guest on April 5, 2017
H ypertension accounts for a substantial portion of cardiovascular disease (CVD) and mortality in the general population. 1, 2 However, the mortality gap between adults with and without hypertension has remained relatively constant over time in some countries. 2 Consequently, efforts are needed to accelerate the decrease in the mortality rate among hypertensive adults.
In this vein, clinical guidelines on hypertension management not only focus on blood pressure (BP) but have also proposed lifestyle and treatment targets for associated CVD risk factors. 3, 4 Some organizations are also launching multifaceted interventions on health factors and behaviors to reduce the burden of CVD. 5, 6 However, the achievement of targets for CVD risk factors associated with hypertension 7, 8 has been studied much less than the control of hypertension itself. [9] [10] [11] Previous research focused on only a few additional risk factors screened in primary care clinics, 7 generally lipids and glucose profile, or reported the association of BP control with lifestyle and some metabolic abnormalities in clinical settings. 8, [12] [13] [14] [15] Lastly, little is known as to whether the diagnosis of hypertension is related to the degree of attainment of cardiometabolic goals.
In this study, we examined the nationwide degree of awareness of hypertension in the adult population of Spain and the achievement of cardiometabolic goals according to awareness of the hypertensive condition of the individuals. We also presented the prevalence and control of all hypertensive patients. To our knowledge, no previous study has reported a comprehensive assessment of the attainment of cardiometabolic targets in hypertensives from the general population of a whole country.
Methods

Study Design and Participants
The data were taken from the Study on Nutrition and Cardiovascular Risk in Spain, for which the methods have been reported elsewhere. 16 In brief, this is a cross-sectional study conducted in 2008-2010 on a representative sample of the noninstitutionalized population of Spain aged ≥18 years.
Study participants were selected by multistage clustered random sampling. The sample was first stratified by province and by size of municipality. Clusters were then selected randomly in 2 stages, municipalities and census sections. Finally, the households within each section were selected by random telephone dialing. Subjects in the households were selected proportionally to the distribution of the population of Spain by sex and age. Information was collected by telephone interview, face-to-face interview, physical examination, and by taking blood and urine samples in the households.
Study participants gave written informed consent. The study was approved by the clinical research ethics committees of the University Hospital La Paz in Madrid and the Hospital Clinic in Barcelona.
Study Variables
BP was measured by certified trained personnel, using standardized procedures, [3] [4] [5] with validated automatic devices (Omron M6) and cuffs of 3 sizes according to arm circumference. Two sets of BP readings were made separated by 90 minutes. In each set, BP was measured 3 times at 1-to 2-minute intervals, after resting ≥3 to 5 minutes in a seated position. In the analyses, BP was calculated as the mean of ≥3 of the last 5 readings.
Hypertension was defined as systolic BP ≥140 mm Hg, and/or diastolic BP ≥90 mm Hg, and/or on current antihypertensive drug treatment. Hypertension awareness among hypertensives was defined as an affirmative answer to the question, "Have you ever been told by the doctor that you had hypertension?" Among treated hypertensives, BP control was defined as systolic BP <140 and diastolic BP <90 mm Hg.
Physical activity and habitual food consumption were evaluated using questionnaires developed from the European Prospective Investigation into Cancer and Nutrition cohort of Spain. [16] [17] [18] Nutrient intake was estimated using composition tables for Spanish and foreign foods. 19, 20 Study participants were asked if they had ever been counseled by a physician on healthy lifestyles, with 3 possible responses: (1) no; (2) yes, but I do not follow it; and (3) yes, and I do follow it. A positive response to 2 or 3 was considered as receiving advice, and a positive response to 3 was considered adherence to the advice.
Weight, height, and waist circumference (WC) were measured twice in each subject under standardized conditions 21 using electronic scales (model Seca 841, precision to 0.1 kg), portable extendable stadiometers (model Ka We 44 444Seca), and flexible, inelastic belt-type tapes. Body mass index (BMI) was calculated as weight in kilograms divided by squared height in meters.
Diabetes mellitus was defined as fasting serum glucose ≥126 mg/ dL or being treated with oral drugs or insulin, and hypercholesterolemia as serum low-density lipoprotein cholesterol >115 mg/dL or receiving lipid-lowering drugs. Individuals also reported previous CVD and use of health care. 3, 16 Each study participant provided 12-hour fasting samples of blood and urine samples at their homes. Total cholesterol was measured by the cholesterol-esterase and cholesterol-oxidase method; high-density lipoprotein cholesterol by the direct method, by elimination/catalase; triglycerides by the glycerol phosphate oxidase method; and low-density lipoprotein cholesterol by the Friedewald formula. Creatinine was determined by Jaffé, alcalin picrate by kinetic reaction, and microalbumin by polyethylene glycol-enhanced immunoturbidimetry. Glucose was measured by the glucose oxidase method. All of the above parameters were measured using the analyzer ADVIA 2400 Chemistry System (Siemens). Hemoglobin A1c was measured by chromatography by high-performance liquid chromatography (analyzer ADAMS A1c HA-8160, Arkray). The laboratory tests were performed centrally at the Center of Biological Diagnosis of the Hospital Clínic in Barcelona, using standard procedures and appropriate quality controls.
Lastly, we calculated the 10-year risk of CVD death for each patient using the SCORE (Systematic COronary Risk Evaluation) equation for low-risk European regions, which includes Spain. 22 High risk was defined as SCORE ≥5%, previous CVD, or diabetes mellitus.
Statistical Analysis
Of the 12 948 study participants, we excluded 874 who lacked data on BP and 117 who did not report their hypertensive status or had missing values for sociodemographic variables, thus we had 11 957 individuals for the analyses. A total of 3983 individuals had hypertension. To determine the achievement of cardiometabolic goals according to hypertension awareness status, we limited the analyses to the 2110 aware hypertensive patients and 1616 unaware hypertensive patients with complete information on variables of interest.
Partially based on previous guidelines and proposals, [3] [4] [5] [6] we classified the cardiovascular health status of hypertensives into 5 categories: lifestyle, biological factors, medical advice, cardioprotective treatment, and use of healthcare services. Goals were taken from the most well-known guidelines and strategies on CVD prevention. [3] [4] [5] [6] The analyses took account of the complex sampling design; thus, individual observations were weighted to reconstruct the Spanish population, and the variances were corrected to obtain appropriate 95% CIs for the main results. The χ 2 test was used to compare proportions and Student t test and ANOVA to compare means. Fisher exact test was used where appropriate.
Multiple logistic regression was used to analyze the association between hypertension awareness and age (<65 or ≥65 years), sex, educational level (university, secondary, primary, or less than primary), and SCORE cardiovascular risk (≥5 versus <5), adjusting for the rest of these variables as appropriate.
Lastly, we selected the sociodemographic and clinical variables, which were statistically significant in bivariate analyses, that compared aware hypertensive patients versus those unaware. The associations between achievement of each of a selection of cardiometabolic goals (yes or no) as outcomes variables and hypertension awareness (unaware as reference) as the main covariate were summarized with odds ratios and their 95% CIs, obtained from logistic regression, adjusting for sociodemographic (age, sex, and educational level) and clinical covariates (study variables described above) that were statistically significant in the bivariate analyses, as appropriate. All of the independent variables were categorized as dichotomic (yes or no) except age and sodium in diet (continuous).
Statistical significance was set at 2-sided P<0.05. The analyses were performed with SPSS package 18.0.
Results
The prevalence of hypertension was 33.3%; 59.4% were aware of their condition. Among those aware, 78.8% were on current drug treatment for hypertension, and only 48.5% of those aware and treated were controlled (22.7% of all hypertensives).
Awareness of Hypertension
Among the 2110 aware hypertensives, mean age was 61.8 years, 52.0% were men, 58.2% had at most a primary education, and mean systolic BP/diastolic BP was 143.7/81.2 mm Hg ( Hypertension awareness was significantly higher among women and those aged ≥65 years and lower among those with less than primary education level, regardless of the other covariates. No statistically significant differences in awareness were found by SCORE risk (odds ratio, 1.01 [95% CI, 0.88-1.16]).
Achievement of Cardiometabolic Goals Among Aware Hypertensive Patients
Among the 2110 aware hypertensives, 85.3% were currently not smokers (one third were ex-smokers; Table 2 ). Although 56.7% had BMI <30 kg/m 2 , only 13.8% had normal BMI (<25 kg/m 2 ), and just 12.3% had normal values for both BMI and WC. Half of the patients did moderate or intense physical activity (≥150 min/wk of moderate intensity or ≥60 min/wk of vigorous intensity), 60.6% had a diet with <10% energy from saturated fat, 38.6% consumed <2.4 g/d of dietary sodium, and only 10.1% consumed <1.5 g/d of dietary sodium.
The hemoglobin A1c goal was attained by 61% of diabetics, and the low-density lipoprotein cholesterol goal was reached by 38.1% of hypercholesterolemics (Table 2) . Lastly, most patients had a normal urinary albumin:creatinine ratio. Up to 70% to 80% of aware hypertensives were given medical lifestyle counseling, but only 60% to 70% of all aware hypertensives adhered to it (Table 2 ). However, adherence to the weight reduction advice was particularly low (36.9%) among patients with excess weight, and only 30.7% were prescribed a specific method for weight loss. Likewise, only 17.4% of daily smokers were offered a smoking cessation strategy.
Approximately 50% to 60% of patients with diabetes mellitus or microalbuminuria were prescribed a blocker of the renin-angiotensin system ( Table 2 ). Most patients were prescribed antidiabetic drugs, but statins or low-dose aspirin (where recommended) were much less prescribed. Flu vaccination in the last year was given to only 15.8% of aware hypertensives aged ≥60 years.
Polytherapy was given to only 50% of uncontrolled aware hypertensives ( Table 2 ). Most patients were informed of the hypertension-related CVD risk, had their BP determined regularly, and visited their physician at ≥1 time per year. Lastly, 62.4% of patients had a self-measurement BP device at their home, and ≈20% had undergone ≥1 ambulatory BP monitoring.
Overall, 36.8% of aware hypertensives met 4 to 7 of the goals on lifestyle, biological factors, medical advice, and cardioprotective medication; 44.7% met 8 or 9, and <20.0% met ≥10. BP control increased with the number of goals met, leveling off at ≥8 goals achieved (Figure) .
In general, aware hypertensives attained more cardiovascular health goals than those unaware, regardless of sociodemographic and clinical covariates (Table 3 ). However, they had significantly higher BMI and WC (Table 3 ). Finally, aware and unaware hypertensives showed a similar frequency of healthy physical activity, saturated fat consumption, and physician-prescribed smoking cessation strategy (Table 3 ).
Discussion
This study is the first to report contemporary data on the achievement of a comprehensive set of goals for BP and other important cardiometabolic characteristics among aware hypertensive patients in an entire country. Moreover, attainment of some important lifestyle targets among aware hypertensives, such as BMI and sodium intake, as well as prescription of specific method of weight loss or smoking cessation strategies, was dramatically low. Figure. Percentage distribution of the number of 15 selected cardiometabolic goals met and corresponding blood pressure control among aware hypertensive patients. Goals were lifestyle (not currently smoking, body mass index [BMI] <25 kg/m 2 and waist circumference [WC] <102/88 cm, moderate/intense physical activity, and sodium consumption <2.4 g/d), biological factors (hemoglobin A1c <6.5% among diabetics, blood pressure <140/90 mm Hg among hypertensives, and low-density lipoprotein cholesterol <115 mg/ dL in dyslipidemic patients), medical advice (adherence to diet to control hypertension, to reducing salt consumption, to losing weight [if overweight], to at least moderate physical activity, and to stopping smoking), and cardioprotective treatment (use of statins, antidiabetic oral drugs, and low-dose aspirin where indicated). 
Magnitude, Awareness, Treatment, and Control of Hypertension
The prevalence of hypertension in adults in Spain is similar to that reported in some other developed countries like England, 9 and higher than in the United States (29%). 11 The use of BP-lowering medication in Spain was high, but the level of BP control was still quite low. BP control in middleaged hypertensives was ≈16.5% in Spain, 26.5% in France, and 40.0% in the United States. 10, 11 Also the limited awareness of hypertension at 59.4% is a major concern and a significant contributor to the limited control of hypertension in the population. There is evidence that the higher stroke mortality rates in Spain than in the United States correspond well with the higher prevalence and lower control of hypertension among Spaniards. 23
Attainment of Specific Cardiometabolic Goals
In line with other European studies performed in clinical settings, 24 the lifestyle prescriptions least frequently given to Spanish aware hypertensives were specific methods for weight loss (only 1 in 3 patients) and for smoking cessation (just 1 in 5 patients). This is consistent with the fact that only a very small percentage of patients achieved both a satisfactory BMI and WC or were ex-smokers. Adherence to medical counseling on other lifestyles was lower than in the United States, where 70.9% of self-reported hypertensives declared that they were changing their eating habits, 79.5% reported using less or no salt, and 68.6% said they were exercising to control their hypertension. 25 Hypertensives in the United States were also more likely than their Spanish counterparts to meet the targets for saturated fat, possibly because lowfat diets have been widely promoted in the United States and because the Mediterranean diet is rich in fat. 26 Although health professionals in Spain usually give specific advice to reduce salt intake to hypertensives, it is very difficult to eat low-salt meals away from home, and only 40% reached the target of <2.4 g/d.
The better control of diabetes mellitus that we found as compared with the United States may partly be explained by the shorter mean duration of diabetes mellitus and the lower frequency of obesity in these patients in Spain than in the United States 27 (data not shown). However, the control of blood lipids among aware hypertensives in Spain is low, which is consistent with the low prescription of statins, clearly lower than in the United States. 28 Also, the percentage of uncontrolled hypertensives on monotherapy was much lower in the United States 29 than in Spain, clearly related to a higher lack of BP control among Spanish hypertensives. The frequent normal urinary albumin:creatinine ratio is consistent with other studies. 30 The use of a blocker of the renin-angiotensin system is the standard of care for patients with hypertension and diabetes mellitus or renal disease. [3] [4] [5] The use of these drugs was lower in our population-based study than in clinical studies in the United States (50% to 60% versus 70% to 80%, respectively). 13 Especially low was the prescription of low-dose aspirin where recommended among diagnosed hypertensives, as compared with studies performed in clinical settings. 31 Lastly, although no formal indication exists for flu vaccination among uncomplicated hypertensives, it is worth mentioning that 84% of known hypertensives ≥60 years did not receive a flu shot, notably higher than in other studies with hypertensive patients. 32 Medical information on the CVD risks related to hypertension was comparable to that in studies in clinical practice. 14 Frequency of BP measurement and of visiting a physician were also consistent with other population-based studies. 33 One in 5 aware hypertensives had undergone an ambulatory blood pressure monitoring, an increasing practice in the last decade, partially explained by the high prevalence of whitecoat hypertension in Spain. 34 Lastly, the high availability of a device for self-measurement at home was similar to that in other population-based studies 31 but, as expected, lower than in studies in clinical settings (80%). 14 Overall, no diagnosed hypertensive patient met all of the cardiometabolic goals/recommendations for lifestyle, biological factors, medical advice, or drugs. Similar to other studies, 15 there was an association between the number of healthy cardiometabolic goals achieved and better BP control.
One striking finding is the lack of difference in the frequency of some healthy lifestyles, such as adequate physical activity and saturated fat intake between aware and unaware hypertensives. This suggests a serious deficiency in the effectiveness of some lifestyle interventions among diagnosed hypertensives. Moreover, aware hypertensives less often had normal BMI and WC than those unaware of their condition. It may be that overweight patients are more likely to be diagnosed with hypertension, and there are no effective tools for reducing weight in most cases.
Methodological Aspects of the Study
One strength of this study is that it provides nationally representative estimates of BP distribution and cardiometabolic goal achievement in the hypertensive population of Spain. Some overestimation of hypertension prevalence (and underestimation of control) could have occurred. We measured BP 6 times, but the time interval between the 2 sets of readings was not very long, and BP tends to fall spontaneously over time. However, some strengths of our study could offset the above effects. First, BP was measured at home in all instances. Second, readings were taken by trained lay personnel rather than physicians, thus reducing the alerting reaction. In addition, we excluded the first BP measurement.
The information on medical advice and its adherence was self-reported and, therefore, is subject to recall bias and social desirability bias (ie, providing a socially acceptable answer rather than the most accurate answer). Consumption estimates were also based on self-reported data and, therefore, are subject to recall bias, which usually leads to underestimates of overall intake. Finally, the cross-sectional study design used does not permit drawing cause-effect relationships.
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The limited available information on achievement of cardiometabolic goals among hypertensive patients in other countries suggest that our findings are not likely to be very different from those many other Western countries and should encourage continuous surveillance and more aggressive management of modifiable cardiometabolic characteristics, beyond BP, in people with hypertension to decisively improve their cardiovascular health. However, future studies are needed to confirm this view.
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